Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients—a double-blind, randomised, prospective, controlled trial
Central venous catheters (CVCs) are essential for the intensive care of patients with haematological illness. Catheter-related infections (CRI) are an important problem in modern medicine, which may lead to life-threatening situations, to prolonged hospitalisation and increased cost. In immunocompro...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
16 April 2005
|
| In: |
Supportive care in cancer
Year: 2005, Volume: 13, Issue: 12, Pages: 993-1000 |
| ISSN: | 1433-7339 |
| DOI: | 10.1007/s00520-005-0812-9 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00520-005-0812-9
|
| Author Notes: | Torben Ostendorf, Andrea Meinhold, Christoph Harter, Hans Salwender, Gerlinde Egerer, Heinrich K. Geiss, Antony D. Ho, Hartmut Goldschmidt |
| Summary: | Central venous catheters (CVCs) are essential for the intensive care of patients with haematological illness. Catheter-related infections (CRI) are an important problem in modern medicine, which may lead to life-threatening situations, to prolonged hospitalisation and increased cost. In immunocompromised patients suffering from haemato-oncological diseases, CRI is a significant factor for adverse outcome. Several clinical studies have shown that CVCs coated with antiseptics such as chlorhexidine and silver-sulfadiazine (CHSS) reduce the risk of catheter-related bacteraemia. Most studies, however, were performed on intensive care patients not suffering from chemotherapy-induced immunosuppression. |
|---|---|
| Item Description: | Gesehen am 25.02.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1433-7339 |
| DOI: | 10.1007/s00520-005-0812-9 |